RougeTx raises USD 58 million Series A led by Angelini Ventures
Angelini Ventures co-led RougeTx’s USD 58 million Series A financing, backed by the European Investment Bank via the Aurea co-investment vehicle. RougeTx develops therapies to restore vascular integrity by targeting pericyte dysfunction.